How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

872 results for

Acne Vulgaris Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Management of scarring due to acne vulgaris

Management of scarring due to acne vulgaris Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2019 PROSPERO

2. Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris

Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Prevalence of H.Pylori (...) in Patients With Acne Vulgaris Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03411733 Recruitment Status : Completed First Posted : January 26, 2018 Last Update Posted : May 2, 2018 Sponsor: Sohag University Information provided by (Responsible Party): Dina Ali, Sohag University Study

2018 Clinical Trials

3. The Safe Management of Acne Vulgaris in Lupus Erythematosus: A Systematic Review with Evidence-Based Treatment Recommendations. (PubMed)

The Safe Management of Acne Vulgaris in Lupus Erythematosus: A Systematic Review with Evidence-Based Treatment Recommendations. To date, there have been no studies that have specifically investigated which medications can and cannot be safely used to treat acne vulgaris in patients who have lupus erythematosus (LE). These patients require a highly individualized treatment approach, as the use of certain acne medications may exacerbate LE symptomology, such as photosensitivity (...) and hypercoagulability.In this systematic review, we examine safety outcomes associated with commonly prescribed oral acne medications, specifically in the context of LE.A literature search, conducted on PubMed/MEDLINE, revealed 146 studies, of which 13 met the criteria. We assigned a level of evidence to each study and sought to determine evidence-based recommendations for each class of drug; each recommendation was then assigned a corresponding grade.There were very few high-quality studies available on this topic

2019 American journal of clinical dermatology

4. How Acne Bumps Cause the Blues: The Influence of Acne Vulgaris on Self-Esteem (PubMed)

How Acne Bumps Cause the Blues: The Influence of Acne Vulgaris on Self-Esteem Acne vulgaris is one of the most common dermatologic complaints. Although dermatologists are skilled at treating acne, invisible psychological scars can be left by the disease. We review 13 articles that examined the effect of acne vulgaris on patients' self-esteem. Overall, these studies demonstrated that acne has a negative effect on self-esteem among patients of all age groups. These effects most strongly affect (...) women and those with severe acne (both subjectively and objectively). Despite the impact on self-esteem, only a minority of patients seek medical treatment, and even fewer seek treatment from a dermatologist. As dermatologists, we are trained in managing acne. We can provide early and effective treatment that improves both the physical and psychological effects. It is up to us to bridge the gap between those suffering from acne and their access to medical treatment.

Full Text available with Trip Pro

2017 International journal of women's dermatology

5. Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age (PubMed)

Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age Hormonal contraception in both reproductive and late reproductive age, as well as contraceptive action, is used also for other indications like dysmenorrhoea, menstrual disorders, endometriosis, acne vulgaris, and hirsutism. Acne vulgaris and hirsutism are important signs related to hyperandrogenaemia and present a serious medical problem for the patients and a challenge (...) for medical doctors in terms of effective treatment. The application of hormonal contraception to treat acne vulgaris and hirsutism requires knowledge of the mechanism of antiandrogenic actions and the possible contraindications and complications. These data are presented in this review.

Full Text available with Trip Pro

2018 PrzeglaÌœd menopauzalny = Menopause review

6. Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel (PubMed)

Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel The majority of available data on the prevalence, grading, and management of acne vulgaris (AV) are based on studies that evaluate facial AV. Data are limited in all of these areas with truncal AV. This study evaluates the efficacy and safety of topical management of truncal AV involving the chest and back in a three-center, open-label, 16-week study. Enrolled subjects (N=20), 12 years of age or older, applied dapsone 7.5% gel

Full Text available with Trip Pro

2018 The Journal of clinical and aesthetic dermatology

7. A novel cognitive stress management technique for acne vulgaris: a short report of a pilot experimental study. (PubMed)

A novel cognitive stress management technique for acne vulgaris: a short report of a pilot experimental study. Acne vulgaris (AV) is one of the most common disorders treated by dermatologists and other healthcare providers. Stress is a well-attested contributor to AV pathogenesis. However, to our knowledge, stress management has not yet been performed in AV patients. In this 8-week experimental study, we primarily examined the effectiveness of a novel method, dubbed Pythagorean Self-Awareness (...) %) patients in the control group showed improvement of the acne stage (relative risk: 3.5, 95% CI 1.5-8.2, P = 0.001). Significant improvements remained after adjusting for age and baseline acne stage. Large to moderate significant effects were observed for perceived stress and negative affect. There were no dropouts and side effects in the PSAI group, whereas compliance reached 100%.Pythagorean Self-Awareness Intervention is a feasible and possibly effective stress management method for AV. Future larger

2018 International Journal of Dermatology Controlled trial quality: uncertain

8. Acne vulgaris

, adverse effects and use of comedongenic make up or face creams should be considered before swapping to an alternative product or the next treatment step. Have I got the right topic? Have I got the right topic? From age 12 years onwards. This CKS topic covers the management of acne vulgaris. This CKS topic does not cover the management of acne secondary to drugs or an underlying condition. There is a separate CKS topic on . The target audience for this CKS topic is healthcare professionals working (...) guidelines Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne [ ]. Management of acne: Canadian clinical practice guideline [ ], A consensus-based practical and daily guide for the treatment of acne patients [ ], European evidence-based (S3) guideline for the treatment of acne – update 2016 [ ], Guidelines of care for the management of acne vulgaris [ ], and Acne: acne vulgaris [ ], and expert opinion in review articles [ ; ; ]. Assessment How should I assess a person

2018 NICE Clinical Knowledge Summaries

9. Quality-of-Life Research in Acne Vulgaris: Current Status and Future Directions. (PubMed)

Quality-of-Life Research in Acne Vulgaris: Current Status and Future Directions. Acne patients may have significant quality-of-life (QoL) impairment, therefore assessment of health-related QoL (HRQoL) in acne patients is recommended by several national and international guidelines as an integral part of acne management. The inclusion of QoL assessment in core outcome sets is now a popular idea. Several acne-specific QoL questionnaires are available but none cover all topics presented in other (...) instruments. The impact of acne on different aspects of QoL may vary between patients from different age groups. The European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes has initiated a study on the relevance of the different QoL topics in acne patients. Detailed recommendations on treatment goals and changes of treatment approaches based on a validated banding system and a minimal clinically important difference in HRQoL questionnaires

2019 American journal of clinical dermatology

10. Combination chemical peels are more effective than single chemical peel in treatment of mild-to-moderate acne vulgaris: A split face comparative clinical trial. (PubMed)

Combination chemical peels are more effective than single chemical peel in treatment of mild-to-moderate acne vulgaris: A split face comparative clinical trial. Successful management of acne involves choosing proper medication. Chemical peeling is a well-known option in treatment of acne vulgaris.To evaluate and compare the clinical efficacy and safety of combination chemical peels vs single peel in treatment of mild-to-moderate acne.The study included 45 patients with mild-to-moderate acne (...) received six sessions with 2-week intervals and followed up for 3 months after the last session. Side effects were reported.Both sides of the face showed significant improvement of acne lesions but improvement was significantly higher and earlier in sides treated by combination peels. Side effects were minimal.In conclusion, combination peels achieved a higher and earlier therapeutic response with a reasonable cost that is maintained for a relatively long periods than single peel. Combination

2019 Journal of cosmetic dermatology

11. Dermocosmetics: beneficial adjuncts in the treatment of acne vulgaris. (PubMed)

Dermocosmetics: beneficial adjuncts in the treatment of acne vulgaris. Introduction: Dermocosmetics are increasingly being recognized as an integral part of acne management. Dermocosmetics may minimize the side effects of acne medications, provide synergistic effects by improving the efficacy of other treatments, and limit exposure to environmental factors such as ultraviolet radiation. We aimed to provide an overview of the active ingredients and different types of preparations used (...) in dermocosmetics for acne, and highlight supporting evidence for their use in clinical practice. Methods: A literature search for selected key words was performed using PubMed. Additional papers were identified based on author expertize. Results and discussion: The different types of active ingredients in dermocosmetics for acne can be classified as: sebum-controlling, antimicrobial, anti-inflammatory, anti-oxidant and/or keratolytic. Such agents may modulate the pathogenic pathways in acne. Dermocosmetics can

2019 Journal of Dermatological Treatment

12. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. (PubMed)

Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. Acne vulgaris, a common and chronic disorder of the pilosebaceous unit, affects upto 85% of adolescent and young adults. While a lot is already known about acne and its treatment, still the gaps in our understanding of acne remains. This article will review the emerging evidence in the complex pathogenesis of acne and provide an overview of the potential future therapy in management of acne vulgaris. Key (...) MessagesWhat is known? Propionibacterium acnes targeted therapy has been the mainstay in the management of acne till now. What is new? Sebocyte activity is controlled via a range of cellular pathways and hormones in addition to androgens. This has opened an array of therapeutic options to be available for treating acne in the near future.

2019 Journal of Dermatological Treatment

13. British Association of Dermatologists guidelines for the management of pemphigus vulgaris

British Association of Dermatologists guidelines for the management of pemphigus vulgaris GUIDELINES BJD British Journal of Dermatology British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017* K.E. Harman, 1 D. Brown, 2 L.S. Exton, 3 R.W. Groves, 4 P.J. Hampton, 5 M.F. Mohd Mustapa, 3 J.F. Setter?eld 4,6 and P.D. Yesudian 7 1 University Hospitals Leicester, Leicester Royal In?rmary, In?rmary Square, Leicester, LE1 5WW, U.K. 2 St John’s Institute (...) Guidelines for the management of pemphigus vulgaris 2017, K.E. Harman et al. 1171there are no skin lesions and a sample for DIF is to be taken from the oral mucosa, the buccal mucosa can be exposed by everting the cheek, placing the thumb at the commissure and re?ecting the corner of the mouth, applying external pressure on the cheek with the index ?nger to present the buccal mucosa. The transport medium into which samples for DIF are placed varies, including saline, Michel’s medium and snap freezing

2017 British Association of Dermatologists

14. A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03128723 Recruitment Status : Completed First Posted : April

2017 Clinical Trials

15. Severe Acne Vulgaris Management

Severe Acne Vulgaris Management Severe Acne Vulgaris Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Severe Acne Vulgaris (...) Management Severe Acne Vulgaris Management Aka: Severe Acne Vulgaris Management , Cystic Acne From Related Chapters II. Indications Moderate to severe Nodular, pustular, or cystic III. Management: Step 1 - Incorporate Moderate Acne Vulgaris Management See Continue Continue (e.g. ) Continue topical antibiotic (e.g. T) May combine with (e.g. ) Consider IV. Management: Step 2 - Start Oral Antibiotics ral Do not anticipate an effect for 6 to 8 weeks Continue antibiotic for minimum of 6 months should be used

2018 FP Notebook

16. Moderate Acne Vulgaris Management

Moderate Acne Vulgaris Management Moderate Acne Vulgaris Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Moderate Acne (...) Vulgaris Management Moderate Acne Vulgaris Management Aka: Moderate Acne Vulgaris Management , Acne Vulgaris Pharmacologic Management From Related Chapters II. Indication Mild to moderate Inflammatory Comedonal III. Management: Step 1 - OTC topical medications (Self-directed treatment) Approach Patient typically presents already using Most providers start at step 2 Indications Comedones Preparations wash (e.g. Cetaphil) daily Topical 2.5% gel in morning 2.5% is as effective as 5-10% Lower strength

2018 FP Notebook

17. Adjunctive Acne Vulgaris Management

Adjunctive Acne Vulgaris Management Adjunctive Acne Vulgaris Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Adjunctive (...) Acne Vulgaris Management Adjunctive Acne Vulgaris Management Aka: Adjunctive Acne Vulgaris Management From Related Chapters II. Management: Options for women Change if already taking one Increase (50ug minimum) Decrease to low androgenic with low androgenic Norlutin Aygestin Demulen Zovia Indications: Women with androgen hypersecretion increased -S increased Dose: 50 to 200 mg orally daily III. Management: Inflammatory Acne Visible decreases inflammatory acne s Moderate to high potency agents

2018 FP Notebook

18. Acne Vulgaris Management

Acne Vulgaris Management Acne Vulgaris Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Acne Vulgaris Management Acne (...) Vulgaris Management Aka: Acne Vulgaris Management , Acne Vulgaris Non-Pharmacologic Management From Related Chapters II. Management: Exacerbating factors to avoid Medications that exacerbate acne Androgenic steroids (e.g. , Testosterone s s ( ) Environment Hot Greasy (fast-food kitchen, garage) Oil based Cosmetics Cosmetics with Lanolin or petroleum jelly Oil based s or s Emotional Stress Physical Pressure (acne mechanica) Tight chinstrap Helmet III. Management: Myths (non-causes of Acne Vulgaris

2018 FP Notebook

19. A Study of S6G5T 3 in the Treatment of Acne Vulgaris

A Study of S6G5T 3 in the Treatment of Acne Vulgaris A Study of S6G5T 3 in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study of S6G5T 3 in the Treatment of Acne Vulgaris (...) provided by (Responsible Party): Sol-Gel Technologies, Ltd. Study Details Study Description Go to Brief Summary: To assess the efficacy of S6G5T-3 compared to its Vehicle when applied once daily for 12 weeks in Patients with acne vulgaris Condition or disease Intervention/treatment Phase Acne Vulgaris Drug: S6G5T-3 Drug: S6G5T-8 Phase 3 Detailed Description: In this Phase 3, double blind, vehicle-controlled study, patients will be admitted into this multi-center, double blind, randomized, vehicle

2018 Clinical Trials

20. A Study of S6G5T-3 in the Treatment of Acne Vulgaris

A Study of S6G5T-3 in the Treatment of Acne Vulgaris A Study of S6G5T-3 in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study of S6G5T-3 in the Treatment of Acne Vulgaris (...) provided by (Responsible Party): Sol-Gel Technologies, Ltd. Study Details Study Description Go to Brief Summary: To assess the efficacy of S6G5T-3 compared to its Vehicle when applied once daily for 12 weeks in Patients with acne vulgaris Condition or disease Intervention/treatment Phase Acne Vulgaris Drug: S6G5T-3 Drug: S6G5T-8 Phase 3 Detailed Description: In this Phase 3, double blind, vehicle-controlled study, patients will be admitted into this multi-center, double blind, randomized, vehicle

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>